Industry: Biotechnology (See others in industry)
Address:Date | FilingType | Incremental Cash | Link to Raw Filing | |||
---|---|---|---|---|---|---|
2025-03-04 | Amended | $1,027,000 | $421,000 | Equity Only | 06c | SEC link |
2024-02-05 | Amended | $606,000 | $600,000 | Equity Only | 06c | SEC link |
2021-08-26 | New | $6,000 | $6,000 | Equity Only | 06c | SEC link |
Name | Role |
---|---|
Gil Blankenship | Director |
Leonard Mills | Director |
Jonathan Pearl | Director |